Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05335993
Title A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors OncoQuest Pharmaceuticals Inc.

peritoneum cancer

ovary epithelial cancer

fallopian tube cancer


Niraparib + Oregovomab

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.